Promising Therapeutic Approach in Pancreatic Cancer: Metabolism-Related Genes
Soohyun Choe1,2, Woori Kwak1,2, Ehyun Kim1
1Department of Medical and Biological Sciences, The Catholic University of Korea, 14662 Bucheon, Republic of Korea.
Abstract:
Most pancreatic cancers are pancreatic ductal adenocarcinomas. This is an extremely lethal disease with poor prognosis and almost no treatment choices. Considering the profound role of the pancreas in the human body, malfunction of this organ can significantly affect quality of life. Although multiple metabolic pathways are altered in cancer cells, certain metabolic gene signatures may be critical for immunotherapy. The reprogrammed metabolism of glucose, amino acids, and lipids can nourish the tumor microenvironment (TME). Previous studies have also shown that reprogrammed metabolism influences immune responses. Tumor-infiltrating immune cells in the TME can adapt their metabolism to blunt the immune system, leading to immunosuppression and tumor progression. The identification of metabolism-related genes (MRGs) associated with immune reactions in pancreatic cancer may lead to improved treatments. This review highlights the characteristics of MRGs in pancreatic cancer and suggests that enhanced anti-cancer therapies could be used to overcome resistance to immunotherapy.
Insights
Metabolism-related genes (MRGs) in pancreatic cancer influence immune responses and tumor growth. Identifying these genes could improve immunotherapy and overcome treatment resistance in this lethal disease.
Area of Science:
- Oncology
- Immunology
- Metabolic pathways
Background:
- Pancreatic ductal adenocarcinoma is a lethal cancer with limited treatment options.
- Altered cellular metabolism is a hallmark of cancer, impacting the tumor microenvironment (TME).
- Metabolic reprogramming in cancer cells affects immune cell function within the TME, promoting immunosuppression.
Purpose of the Study:
- To review the characteristics of metabolism-related genes (MRGs) in pancreatic cancer.
- To explore the link between metabolic gene signatures and immune reactions in pancreatic cancer.
- To identify potential therapeutic targets for enhancing immunotherapy.
Main Methods:
- Literature review of studies on pancreatic cancer metabolism and immunology.
- Analysis of metabolic pathways altered in pancreatic cancer.
- Examination of the role of MRGs in immune cell function within the TME.
Main Results:
- Metabolic reprogramming, including glucose, amino acid, and lipid metabolism, supports tumor growth and the TME.
- Tumor-infiltrating immune cells adapt their metabolism to create an immunosuppressive environment.
- Specific MRGs are associated with immune responses in pancreatic cancer.
Conclusions:
- MRGs play a critical role in pancreatic cancer progression and immune evasion.
- Targeting MRGs may offer novel strategies to enhance immunotherapy efficacy.
- Further research into MRGs could lead to improved treatment approaches for pancreatic cancer.
Related Concept Videos
02:57Targeted Cancer Therapies
There are several types of targeted therapies against...
02:50Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
03:03mTOR Signaling and Cancer Progression
The mTOR pathway or the...
02:53Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...